The role of miRNAs as a predictor of multicentricity in breast cancer
- 114 Downloads
Expression profiles of miRNAs are shown to be different in various cancers to regulate expression of mRNA or to have a role in inhibition of translation, thus it shows the possible effect in progression, invasion and metastasis of breast cancer cells. The effect of breast conserving treatment in local recurrence and survival rates for the patients who have multicentric breast cancer is still controversial. In our study, we intended to evaluate the foresight of 84 miRNAs which are identified in breast cancer for having differentiated expressions. Thirty-one patients with unifocal and 26 patients with multicentric breast cancer were included in this study. These tissue samples of both malignant and normal breast tissues were kept in RNA later solution at − 80 °C. Eighty-four miRNAs were studied with miScript miRNA PCR Array Human Breast Cancer kit. Fold change, cut off value was accepted as four. In unifocal group, there were 13 upregulated and five downregulated miRNAs and in multicentric group, there were three upregulated and seven downregulated miRNAs. To reach better results for breast cancer diagnosis and treatment, it is important to enlighten tumor biology, and pay attention to target and individual therapy. Thus, miRNAs have potential role in identifying tumor characteristics in supporting diagnosis and resulting with better evaluated disease for better treatment results with individual strategies.
KeywordsBreast cancer Expression MicroRNAs Multicentric Multifocal
This research was supported by the Scientific Research Projects Unit of Bezmialem Vakif University (Project No.: BVU 12.2013/7).
Compliance with ethical standards
Conflict of interest
No conflict of interest was declared by the authors.
This study was reviewed and approved by Ethics Committee of Bezmialem Vakıf University, School of Medicine (11.27.2013/no:1206642/050/01/04/231). Each patient involved in this study gave written informed consent.
- 3.Shaikh T, Tam TY, Li T, Hayes SB, Goldstein L, Bleicher R, Boraas M, Sigurdson E, Ryan PD, Anderson P (2015) Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery type. Breast J Mar-Apr 21(2):121–126. https://doi.org/10.1111/tbj.12366 CrossRefGoogle Scholar
- 5.Chiang CH, Hou MF, Hung WC (2013) Up-regulation of miR-182 by β-catenin in breast cancer increases tumorigenicity and invasiveness by targeting the matrix metalloproteinase inhibitor RECK. Biochim Biophys Acta 1830(4):3067–3076. https://doi.org/10.1016/j.bbagen.2013.01.009 CrossRefPubMedGoogle Scholar
- 7.Attema JL, Bert AG, Lim YY, Kolesnikoff N, Lawrence DM, Pillman KA, Smith E, Drew PA, Khew-Goodall Y, Shannon F, Goodall GJ (2013) Identification of an enhancer that increases miR-200b-200a-429 gen expression in breast cancer cells. PLoS ONE 8(9):e75517. https://doi.org/10.1371/journal.pone.0075517 CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang H, Zhang X, Wei X, Wang D, Cui M, Liu C (2015) micro-RNA-1 down regulates proliferation and migration of breast cancer stem cells by inhibiting catenin pathway. Oncotarget 6(39):41638–41649. https://doi.org/10.18632/oncotarget.5873 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, Canu V, Mori F, Antoniani B, Di Benedetto A, Santoro R, Germoni S, De Angelis F, Cambria A, Avraham R, Grasso G, Strano S, Muti P, Mottolese M, Yarden Y, Domany E, Blandino G (2012) miR-10b, a master inhibitor of the cell cycle, is down regulated in human breast tumours. EMBO Mol Med 4(11):1214–1229. https://doi.org/10.1002/emmm.201201483 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Ryan J, Tivnan A, Fay J, Bryan K, Meehan M, Creevey L, Lynch J, Bray IM, O’Meara A, Tracey L, Davidoff AM, Stallings RL (2012) MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome. Br J Cancer 107(6):967–976. https://doi.org/10.1038/bjc.2012.356 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, Barroilhet LM, Ng AS, Wong RR, Wang VW, Mok SC, Smith DI, Berkowitz RS, Wong YF (2012) Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer 130(5):1036–1045. https://doi.org/10.1002/ijc.26060 CrossRefPubMedGoogle Scholar
- 24.Imam JS, Plyler JR, Bansal H, Prajapati S, Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, Buddavarapu KC, Broaddus R, Hornsby P, Tomlinson G, Dome J, Vadlamudi RK, Pertsemlidis A, Chen Y, Rao MK (2012) Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. PLoS ONE 7(12):e52397. https://doi.org/10.1371/journal.pone.0052397 CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Kikkawa N, Hanazawa T, Fujimura L, Nohata N, Suzuki H, Chazono H, Sakurai D, Horiguchi S, Okamoto Y, Seki N (2010) miR-489 is a tumour suppressive miRNA target PTPN11 in hypofaryngeal squamos cell carcinoma. Br J Cancer 103(6):877–884. https://doi.org/10.1038/sj.bjc.6605811 CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Jiang L, He D, Yang D, Chen Z, Pan Q, Mao A, Cai Y, Li X, Xing H, Shi M, Chen Y, Bruce IC, Wang T, Jin L, Qi X, Hua D, Jin J, Ma X (2014) miR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway. FEBS Lett 588(11):2009–2015. https://doi.org/10.1016/j.febslet.2014.04.024 CrossRefPubMedGoogle Scholar